News & Press

SNIPR_BIOME_Lab.jpg
 
 

News & Press


 
SNIPR_BIOME_IDA_Techtopia.jpg

IDA / 08.19

Dansk CRISPR-start-up laver penicillins afløser

 
SNIPR_Biome_Pharma.jpg

Press Release / 06.19

Biotekfirmaet SNIPR Biome vil ramme bakterierne helt præcist

 
SNIPR_Lab.jpg

Press Release / 05.19

US Patent Grants Strengthen SNIPR BIOME’s Approach to Enhance Immuno-Oncology Outcomes by Microbiome Modulation

 
Bio_Century_SNIPR.jpg

BioCentury Innovations / 05.19

SNIPR: Turning CRISPR into a microbiome suicide

 
Fierce_Biotech_SNIPR.jpg

FierceBiotech / 03.19

SNIPR raises $50M to use CRISPR to modulate the microbiome

 
Bio_Century.jpg

BioCentury / 03.19

$50M series A for CRISPR microbiome play SNIPR BIOME

 
20190311_Endpoint.jpg

Endpoint News / 03.19

Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech

 
20190311_BORSEN.jpg

Børsen / 03.19

Biotekbaby får 320 mio til at finde penicillins afløser

 
SNIPR_Biome_Press.jpg

Press Release / 03.19

SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials

 
Press_01.jpg

Børsen / 08.17

Lundbeck-ejer i millionsats på bakteriedræberen SNIPR

 
Press_02.jpg

Berlingske Tidene / 08.17

Lundbeck-ejer i millionsats på bakteriedræbere

 
Press_03.jpg

Lundbeckfonden / 08.17

Lundbeck-ejer investerer i CRISPR-teknologi til redigering af bakteriers gener